// App-Quantinova.ai

1033 : Association between distinct intratumoral and stromal tumor infiltrating immune cells and pathologic complete response (pCR) in different breast cancer subtypes after neoadjuvant chemotherapy (NAC).

Researchers

Presenter

  • Lucia Gonzalez-Cortijo

Principal Investigators

  • Raquel Murillo

  • Agustin Acevedo

  • Ricardo Sainz de la Cuesta

  • Gines Hernandez-Cortes

  • Vicente Martinez de Vega

  • Susana Linares

  • Ramon Perez-Carrion

  • Federico Gonzalez

  • Cristina Rodriguez-Marquez

  • Alexandra Henriquez

  • Elia del Cerro

  • Ana Diaz-Gavela

  • Antonio Maldonado

  • Silvia Fuertes

  • Jose Luis Martin del Yerro

  • Ignacio Sanz

  • Javier Hornedo

Medical Centers

  • Hospital Universitario Quiron Madrid, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • erb-b2 receptor tyrosine kinase 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Trastuzumab

  • Doxorubicin

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved